Sensus Healthcare, Inc (NASDAQ:SRTS) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET
Company Participants
Kim Golodetz - IR
Joseph Sardano - Chairman and CEO
Michael Sardano - President and General Counsel
Javier Rampolla - CFO
Conference Call Participants
Scott Henry - ROTH Capital
Anthony Vendetti - Maxim Group
Ben Haynor - Alliance Global Partners
Operator
Welcome to the Sensus Healthcare Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.
I would now like to turn the conference over to Kim Sutton Golodetz with LHA Investor Relations. Please go ahead.
Kim Golodetz
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities law. All statements other than historical facts that address activities Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future are forward-looking statements. The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, August 3, 2023. Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements except as required by law. All forward-looking statements are subject to risks and uncertainties as described in the company's Forms 10-K and 10-Q.
During today's call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors, yet they should not be considered as a substitute for GAAP, nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release.
With that said, I'd like to turn the call over to Joe Sardano. Joe?
Joseph Sardano
Thank you, Kim, and good afternoon, everyone.
Our second quarter financial results showed improvement over the first quarter. During Q2, we shipped 13 systems, including four SRT systems outside the US, and six SRT-100 Vision systems up from 10 systems shipped during the first quarter of 2023, but down from 33 systems shipped in the prior year quarter.
During the quarter, we did achieve a milestone. We have now shipped over 700 systems - 708 to be exact in total, and are making progress as we drive towards 1,000 systems within the next couple of years.